April 6, 2009

$22 Price Target on ISIS Pharmaceutical

Zacks has a $22 price target on ISIS pharmaceutical this morning. They call one of their products, Mipomersen, "one of the largest potential blockbuster drugs to come to market in the next few years."

No comments: